All News #Library
Biotech
Otsuka buys Transcend in $1.2B deal, nabbing MDMA analog
28 Mar 2026 //
PR NEWSWIRE
Otsuka Unveil New Repinatrabit Open-Label Data in Phenylketonuria
12 Mar 2026 //
BUSSINESSWIRE
Biodexa Announces Exclusive License of Otsuka’s OPB-171775
06 Feb 2026 //
GLOBENEWSWIRE
Otsuka Pharma Seeks FDA Approval For Centanafadine In ADHD
24 Nov 2025 //
BUSINESSWIRE
4DMT Announces License Agreement with Otsuka Pharmaceutical
30 Oct 2025 //
GLOBENEWSWIRE
Cantargia Closes the Acquisition of CAN10 by Otsuka
11 Sep 2025 //
ACCESSWIRE
Harbour BioMed, Otsuka Partner to Advance BCMAxCD3 T-Cell Engager
23 Jun 2025 //
PR NEWSWIRE
Otsuka Submits New Drug Application in Japan for Voclosporin
10 Nov 2023 //
PRESS RELEASE
New England Journal of Medicine Publishes Complete Results of Positive Phase 2 Trial of Sibeprenlimab
06 Nov 2023 //
PRESS RELEASE

Market Place
Sourcing Support